Trial · NCT01397552
Dexamethasone Versus Depo Medrol in Lumbar Epidurals
NCT01397552, Not applicable, Terminated, State University of New York - Upstate Medical University; results first posted 2018-12-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dexamethasone Versus Depo Medrol in Lumbar Epidurals. Trials, record NCT01397552. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01397552
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dexamethasone Versus Depo Medrol in Lumbar Epidurals
- NCT number
- NCT01397552
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 8 participants, actual
- Lead sponsor
- State University of New York - Upstate Medical University
- Conditions
- Lumbar Spine Disc Herniation, Lumbar Radiculitis, Lumbar Back Pain
- Interventions
- Dexamethasone, methylprednisolone acetate
- First posted
- 2011-07-19
- Last updated
- 2023-11-22
- Results first posted
- 2018-12-04
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To Determine if One Medication is Better at Relieving Pain Than the Other. | 12 wk post injection | Subjects will be asked to return at 2 wks, 6 wks and 12 weeks the above time points to complete outcome measurements questionnaires and undergo a neurological examination, the 12 weeks outcome should show improvement s/p injection |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | To Determine if One Medication is Better at Relieving Pain Than the Other. | 12 wk post injection | enrollment was too low and half of the subjects did not complete study requirements, no data collected for analysis |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Dexamethasone | 4 | |
| Overall Study | STARTED | Methylprednisolone Acetate | 4 | |
| Overall Study | COMPLETED | Dexamethasone | 1 | |
| Overall Study | COMPLETED | Methylprednisolone Acetate | 3 | |
| Overall Study | NOT COMPLETED | Dexamethasone | 3 | |
| Overall Study | NOT COMPLETED | Methylprednisolone Acetate | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Dexamethasone | 0 | 4 |
| Total, all-cause mortality | Methylprednisolone Acetate | 0 | 4 |
| Total, other adverse events | Dexamethasone | 0 | 4 |
| Total, other adverse events | Methylprednisolone Acetate | 0 | 4 |
| Total, serious adverse events | Dexamethasone | 0 | 4 |
| Total, serious adverse events | Methylprednisolone Acetate | 0 | 4 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Dexamethasone vs Methylprednisolone Acetate: deaths from any cause | Trial comparisons |
| Dexamethasone vs Methylprednisolone Acetate: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01397552
GET https://conductscience.org/api/trials/v1/NCT01397552/registered